These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 29428298)
61. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection. Hammond SL; Leek AN; Richman EH; Tjalkens RB PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806 [TBL] [Abstract][Full Text] [Related]
62. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Broekman ML; Comer LA; Hyman BT; Sena-Esteves M Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198 [TBL] [Abstract][Full Text] [Related]
64. AAV-Mediated Gene Delivery to the Lung. van Lieshout LP; Domm JM; Wootton SK Methods Mol Biol; 2019; 1950():361-372. PubMed ID: 30783985 [TBL] [Abstract][Full Text] [Related]
65. Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid. Vercauteren K; Hoffman BE; Zolotukhin I; Keeler GD; Xiao JW; Basner-Tschakarjan E; High KA; Ertl HC; Rice CM; Srivastava A; de Jong YP; Herzog RW Mol Ther; 2016 Jun; 24(6):1042-1049. PubMed ID: 27019999 [TBL] [Abstract][Full Text] [Related]
66. Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology. Hordeaux J; Buza EL; Dyer C; Goode T; Mitchell TW; Richman L; Denton N; Hinderer C; Katz N; Schmid R; Miller R; Choudhury GR; Horiuchi M; Nambiar K; Yan H; Li M; Wilson JM Hum Gene Ther; 2020 Aug; 31(15-16):808-818. PubMed ID: 32845779 [TBL] [Abstract][Full Text] [Related]
67. Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8. Khabou H; Desrosiers M; Winckler C; Fouquet S; Auregan G; Bemelmans AP; Sahel JA; Dalkara D Biotechnol Bioeng; 2016 Dec; 113(12):2712-2724. PubMed ID: 27259396 [TBL] [Abstract][Full Text] [Related]
68. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Kwon I; Schaffer DV Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830 [TBL] [Abstract][Full Text] [Related]
69. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Samaranch L; Salegio EA; San Sebastian W; Kells AP; Foust KD; Bringas JR; Lamarre C; Forsayeth J; Kaspar BK; Bankiewicz KS Hum Gene Ther; 2012 Apr; 23(4):382-9. PubMed ID: 22201473 [TBL] [Abstract][Full Text] [Related]
70. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426 [TBL] [Abstract][Full Text] [Related]
71. The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier. Hordeaux J; Yuan Y; Clark PM; Wang Q; Martino RA; Sims JJ; Bell P; Raymond A; Stanford WL; Wilson JM Mol Ther; 2019 May; 27(5):912-921. PubMed ID: 30819613 [TBL] [Abstract][Full Text] [Related]
72. Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. Grimm D; Pandey K; Nakai H; Storm TA; Kay MA J Virol; 2006 Jan; 80(1):426-39. PubMed ID: 16352567 [TBL] [Abstract][Full Text] [Related]
73. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies. Sun J; Hua B; Chen X; Samulski RJ; Li C Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688 [TBL] [Abstract][Full Text] [Related]
74. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787 [TBL] [Abstract][Full Text] [Related]
75. Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations. Boucas J; Lux K; Huber A; Schievenbusch S; von Freyend MJ; Perabo L; Quadt-Humme S; Odenthal M; Hallek M; Büning H J Gene Med; 2009 Dec; 11(12):1103-13. PubMed ID: 19777441 [TBL] [Abstract][Full Text] [Related]
76. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands. Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165 [TBL] [Abstract][Full Text] [Related]
77. Ligand Coupling to the AAV Capsid for Cell-Specific Gene Transfer. Reul J; Muik A; Buchholz CJ Methods Mol Biol; 2019; 1950():35-50. PubMed ID: 30783967 [TBL] [Abstract][Full Text] [Related]